The objectives of this program are to train graduate students and postdoctoral fellows for a research career in academia, government research agencies, or pharmaceutical companies in the general area of cancer and viral chemotherapy. The program is designed to provide a strong biochemical, biophysical and physiological background which wilt enable the individual (1) to identify targets for the development of anticancer and antiviral drugs; (2) to design and synthesize an agent to attack the specific target; (3) to elucidate the molecular basis for the interaction; and (4) to determine specificity of action (Therapeutic Index) in cell culture and, when possible, to extend studies into appropriate animal models. To achieve these ends modern techniques of cell and molecular biology, structure biology, chemistry, biochemistry, physiology and biophysics are available for application by the trainee. The trainee will have constant exposure to a variety of research programs of the faculty, as well as to over fifty senior postdoctoral fellows who provide an additional resource for the trainees. Strong ties exist with the Yale Comprehensive Cancer Center enabling interested studies to follow clinician and scientist from a variety of other departments and disciplines at Yale including Biology, Chemistry, Pathology, Human Genetics, Medicine, Immunobiology, Physiology, Cell Biology and Neuroscience. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009085-32
Application #
7128155
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1985-07-01
Project End
2010-06-30
Budget Start
2006-09-25
Budget End
2007-06-30
Support Year
32
Fiscal Year
2006
Total Cost
$389,185
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Chen, Catherine; Nimlamool, Wutigri; Miller, Chad J et al. (2017) Rational Redesign of a Functional Protein Kinase-Substrate Interaction. ACS Chem Biol 12:1194-1198
Chen, Catherine; Ha, Byung Hak; Thévenin, Anastasia F et al. (2014) Identification of a major determinant for serine-threonine kinase phosphoacceptor specificity. Mol Cell 53:140-7
Bannwarth, Ludovic; Goldberg, Allison B; Chen, Catherine et al. (2012) Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening. Chem Biol 19:875-82
Chiswell, Brian P; Stiegler, Amy L; Razinia, Ziba et al. (2010) Structural basis of competition between PINCH1 and PINCH2 for binding to the ankyrin repeat domain of integrin-linked kinase. J Struct Biol 170:157-63
Roberts, Anne; Furdui, Cristina; Anderson, Karen S (2010) Observation of a chemically labile, noncovalent enzyme intermediate in the reaction of metal-dependent Aquifex pyrophilus KDO8PS by time-resolved mass spectrometry. Rapid Commun Mass Spectrom 24:1919-24
Petri, Edward T; Celic, Andjelka; Kennedy, Scott D et al. (2010) Structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity. Proc Natl Acad Sci U S A 107:9176-81
Chen, Catherine; Turk, Benjamin E (2010) Analysis of serine-threonine kinase specificity using arrayed positional scanning peptide libraries. Curr Protoc Mol Biol Chapter 18:Unit 18.14
Zhang, Zhenfeng; Stiegler, Amy L; Boggon, Titus J et al. (2010) EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 1:497-514
Casuscelli, Jozefina; Schmidt, Stefan; DeGray, Brenda et al. (2009) Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2. Am J Physiol Renal Physiol 297:F1310-5
Blachford, Courtney; Celi?, Andjelka; Petri, Edward T et al. (2009) Discrete proteolysis of neuronal calcium sensor-1 (NCS-1) by mu-calpain disrupts calcium binding. Cell Calcium 46:257-62

Showing the most recent 10 out of 65 publications